Morepen Executive and Leadership Team

Varun Suri, the Chief Executive Officer, Consumer Business at Morepen, directs the strategic expansion of the consumer healthcare and grooming divisions. Overseeing product lifecycle management, the Chief Executive Officer, Consumer Business ensures that brands like Dr. Morepen and Gubb World maintain market relevance across diverse demographics. This leadership role involves aligning internal manufacturing capabilities with shifting retail trends to capture greater market share. By optimizing supply chain efficiency for OTC products, Varun Suri directly impacts the company's ability to reach over 100 million consumers. Furthermore, Suri coordinates with the board to prioritize investments in high-growth categories, ensuring that the consumer business remains a primary revenue driver. Through constant evaluation of market data, Suri secures long-term brand loyalty and operational excellence within the competitive pharmaceutical landscape.

Amita Sharma, the Head Chief Operating Officer, Api PPC & Commercial at Morepen, manages the complex manufacturing processes and commercial logistics for Active Pharmaceutical Ingredients. Overseeing production quality and regulatory compliance, the Head Chief Operating Officer, Api PPC & Commercial ensures that all facilities meet stringent USFDA and WHO GMP standards. This leadership role involves coordinating large-scale output to support the company's extensive export network spanning over 80 countries. Amita Sharma optimizes operational workflows to reduce costs while maintaining the high purity levels required for global pharmaceutical distribution. By integrating commercial objectives with manufacturing capacity, Sharma ensures that the supply chain remains resilient against market fluctuations. Through rigorous oversight of technical operations, Sharma guarantees that the company delivers consistent, high-quality ingredients to partners worldwide, reinforcing the firm's reputation for excellence in the global API market.

Tj Anthony, the President, Generics, OTC & Business Development (US) at Morepen, leads the strategic penetration of the North American pharmaceutical market. Directing business development initiatives, the President, Generics, OTC & Business Development (US) identifies key partnerships and distribution channels to expand the reach of generic formulations and OTC products. This role involves navigating complex regulatory environments to ensure seamless product entry and sustained compliance. Tj Anthony collaborates with internal R&D teams to align product offerings with specific regional demands, thereby maximizing the company's competitive advantage in the US. By fostering relationships with major healthcare providers and retail chains, Anthony drives revenue growth and strengthens the company's footprint in the region. Through proactive market analysis, Anthony ensures that the organization remains agile, effectively capturing emerging opportunities within the highly regulated and demanding North American healthcare sector.

Kushal Suri, the President, International Growth at Morepen, spearheads the expansion of the company's global footprint beyond existing markets. Overseeing international trade relations, the President, International Growth identifies high-potential regions for the distribution of APIs and finished formulations. This leadership role involves building robust networks with global distributors and regulatory bodies to facilitate entry into new territories. Kushal Suri coordinates with cross-functional teams to adapt product strategies to local market requirements, ensuring that the company's offerings resonate with diverse international consumer bases. By driving initiatives that enhance global brand recognition, Suri supports the company's mission to reach millions of new patients and customers. Through strategic planning and execution, Suri secures long-term growth, positioning the organization as a formidable player in the international pharmaceutical industry while maintaining the highest standards of quality and innovation.

Priti Mahwar, the Chief Marketing Officer at Morepen, architects the brand identity and promotional strategies for the entire pharmaceutical and consumer product portfolio. Managing multi-channel campaigns, the Chief Marketing Officer drives engagement across digital and traditional platforms to elevate the visibility of Dr. Morepen and Gubb World. This role requires close collaboration with product development teams to translate technical pharmaceutical benefits into compelling consumer narratives. Priti Mahwar monitors market sentiment and competitive positioning to refine messaging, ensuring consistent brand growth across domestic and international territories. By leveraging data-driven insights, Mahwar optimizes marketing spend to maximize return on investment. Ultimately, the Chief Marketing Officer strengthens the company's market presence, fostering deep connections with consumers while supporting the broader organizational goal of enhancing lives through accessible healthcare solutions.